KN0 logo

Dicot Pharma DB:KN0 Stock Report

Last Price

€0.0086

Market Cap

€12.9m

7D

-20.4%

1Y

7.5%

Updated

06 Oct, 2024

Data

Company Financials

Dicot Pharma AB Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Dicot Pharma
Historical stock prices
Current Share PriceSEK 0.0086
52 Week HighSEK 0.042
52 Week LowSEK 0.003
Beta1.47
11 Month Change-36.76%
3 Month Change-67.30%
1 Year Change7.50%
33 Year Changen/a
5 Year Changen/a
Change since IPO38.71%

Recent News & Updates

Recent updates

Shareholder Returns

KN0DE PharmaceuticalsDE Market
7D-20.4%-3.0%-1.9%
1Y7.5%-13.2%12.3%

Return vs Industry: KN0 exceeded the German Pharmaceuticals industry which returned -13.2% over the past year.

Return vs Market: KN0 underperformed the German Market which returned 12.3% over the past year.

Price Volatility

Is KN0's price volatile compared to industry and market?
KN0 volatility
KN0 Average Weekly Movement37.3%
Pharmaceuticals Industry Average Movement5.4%
Market Average Movement4.9%
10% most volatile stocks in DE Market10.8%
10% least volatile stocks in DE Market2.4%

Stable Share Price: KN0's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: KN0's weekly volatility (37%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
20153Elin Trampewww.dicotpharma.com

Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It is developing LIB-01 for the treatment of erectile dysfunction and premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024.

Dicot Pharma AB Fundamentals Summary

How do Dicot Pharma's earnings and revenue compare to its market cap?
KN0 fundamental statistics
Market cap€12.92m
Earnings (TTM)-€4.48m
Revenue (TTM)n/a

0.0x

P/S Ratio

-2.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
KN0 income statement (TTM)
RevenueSEK 0
Cost of RevenueSEK 0
Gross ProfitSEK 0
Other ExpensesSEK 50.94m
Earnings-SEK 50.94m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Oct 31, 2024

Earnings per share (EPS)-0.062
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did KN0 perform over the long term?

See historical performance and comparison